Results 31 to 40 of about 124,514 (155)

Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections [PDF]

open access: yesAntibiotics, 2019
Carbapenem-resistant Enterobacteriaceae (CRE) have become a public health threat worldwide. There are three major mechanisms by which Enterobacteriaceae become resistant to carbapenems: enzyme production, efflux pumps and porin mutations. Of these, enzyme production is the main resistance mechanism.
Beatriz Suay-García   +1 more
openaire   +4 more sources

Case series of carbapenemase-producing Enterobacteriaceae osteomyelitis: Feel it in your bones

open access: yesJournal of Global Antimicrobial Resistance, 2020
Objectives: Limited data have been reported regarding osteomyelitis due to carbapenemase-producing Enterobacteriaceae (CPE), including co-infections with extended-spectrum β-lactamase (ESBL)-producing micro-organisms.
B. Davido   +12 more
doaj   +1 more source

Enterobacteriaceae Bloodstream Infections: Presence of Integrons, Risk Factors, and Outcome [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2007
ABSTRACT A prospective observational study was conducted to identify factors associated with bloodstream infections (BSIs) caused by integron-carrying Enterobacteriaceae and to evaluate the clinical significance of integron carriage. Consecutive patients with Enterobacteriaceae BSIs
Daikos, George L.   +8 more
openaire   +4 more sources

Endogenous Enterobacteriaceae underlie variation in susceptibility to Salmonella infection [PDF]

open access: yesNature Microbiology, 2019
Lack of reproducibility is a prominent problem in biomedical research. An important source of variation in animal experiments is the microbiome, but little is known about specific changes in the microbiota composition that cause phenotypic differences.
Eric M. Velazquez   +16 more
openaire   +4 more sources

Detection and characterization of carbapenemase-producing Enterobacteriaceae in cancer patients: first Sri Lankan report of blaVIM in Enterobacteriaceae

open access: yesJournal of Infection in Developing Countries
Background: Carbapenem-resistant Enterobacteriaceae (CRE) are an important cause of infections in cancer patients. The proportion of carbapenem resistance and the types of carbapenemase-encoding genes in Enterobacteriaceae isolated from cancer patients ...
Gayashan Chathuranga   +3 more
doaj   +1 more source

Clinical and Mortality Risk Factors in Bloodstream Infections with Carbapenem-Resistant Enterobacteriaceae

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2017
Objective. To investigate the risk factors underlying the occurrence and mortality of bloodstream infections (BSIs) with carbapenem-resistant Enterobacteriaceae (CRE). Methods.
Xiaopeng Li, Huan Ye
doaj   +1 more source

The Gut of Healthy Infants in the Community as a Reservoir of ESBL and Carbapenemase-Producing Bacteria

open access: yesAntibiotics, 2020
The recent rapid rise of multi-drug resistant Enterobacteriaceae (MDR-E) is threatening the treatment of common infectious diseases. Infections with such strains lead to increased mortality and morbidity.
Ali F. Saleem   +12 more
doaj   +1 more source

Microbiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarity. [PDF]

open access: yesPLoS ONE, 2015
Plasmid-mediated AmpC beta-lactamase-producing (pAmpC) Enterobacteriaceae are increasing worldwide, difficult to identify and often confounded with extended-spectrum beta-lactamase (ESBL) producers.
Anna Conen   +5 more
doaj   +1 more source

An analysis of risk factors for carbapenem-resistant Enterobacteriaceae infection

open access: yesJournal of Global Antimicrobial Resistance, 2022
This study aims to explore the high-risk factors of carbapenem-resistant Enterobacteriaceae (CRE) infection of hospitalised patients in high-risk departments.This study is a multicentre, retrospective study. CRE screening positive patients from 1 January 2016 to 31 December 2018 of high-risk departments in five tertiary first-class teaching hospitals ...
Yan Gao   +14 more
openaire   +3 more sources

Clinical outcomes of Enterobacteriaceae infections stratified by carbapenem MICs. [PDF]

open access: yesJ Clin Microbiol, 2015
ABSTRACT The Clinical and Laboratory Standards Institute (CLSI) lowered the MIC breakpoints for meropenem and imipenem from 4 mg/liter to 1 mg/liter for Enterobacteriaceae in 2010. The breakpoint change improves the probability of pharmacodynamic target attainment and eliminates the need for microbiology ...
Patel TS, Nagel JL.
europepmc   +4 more sources

Home - About - Disclaimer - Privacy